PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $5,801,000 | +53.0% | 813,567 | +412.5% | 0.01% | +125.0% |
Q4 2019 | $3,791,000 | +49.2% | 158,733 | +116.7% | 0.00% | 0.0% |
Q1 2019 | $2,541,000 | +117.0% | 73,235 | +22.1% | 0.00% | +100.0% |
Q4 2018 | $1,171,000 | -70.2% | 60,000 | -59.4% | 0.00% | -60.0% |
Q3 2018 | $3,931,000 | -75.1% | 147,609 | -64.7% | 0.01% | -76.2% |
Q2 2018 | $15,816,000 | -40.4% | 418,738 | -48.4% | 0.02% | -41.7% |
Q1 2018 | $26,523,000 | -47.2% | 812,122 | -21.3% | 0.04% | -47.8% |
Q4 2017 | $50,266,000 | -9.7% | 1,032,577 | +0.2% | 0.07% | -19.8% |
Q3 2017 | $55,652,000 | -15.7% | 1,030,022 | -12.3% | 0.09% | -21.1% |
Q2 2017 | $65,996,000 | +156.9% | 1,174,930 | +79.2% | 0.11% | +142.2% |
Q1 2017 | $25,688,000 | +1465.4% | 655,490 | +796.8% | 0.04% | +1400.0% |
Q4 2016 | $1,641,000 | -61.8% | 73,093 | -61.4% | 0.00% | -62.5% |
Q3 2016 | $4,298,000 | +459.6% | 189,226 | +481.8% | 0.01% | +700.0% |
Q2 2016 | $768,000 | +97.9% | 32,526 | +70.8% | 0.00% | 0.0% |
Q1 2016 | $388,000 | -88.2% | 19,039 | -70.3% | 0.00% | -80.0% |
Q4 2015 | $3,300,000 | +56.6% | 64,143 | +29.8% | 0.01% | +66.7% |
Q3 2015 | $2,107,000 | -50.7% | 49,435 | -47.3% | 0.00% | -50.0% |
Q2 2015 | $4,272,000 | +212.3% | 93,780 | +160.1% | 0.01% | +200.0% |
Q1 2015 | $1,368,000 | +65.8% | 36,050 | +23.8% | 0.00% | +100.0% |
Q4 2014 | $825,000 | +109.9% | 29,109 | +87.5% | 0.00% | 0.0% |
Q3 2014 | $393,000 | -25.1% | 15,527 | -13.7% | 0.00% | 0.0% |
Q2 2014 | $525,000 | -91.1% | 17,999 | -91.9% | 0.00% | -88.9% |
Q3 2013 | $5,912,000 | +8.9% | 221,000 | 0.0% | 0.01% | -10.0% |
Q2 2013 | $5,430,000 | – | 221,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |